Neoadjuvant Pembrolizumab and Chemotherapy in Resectable Esophageal Cancer: An Open-Label, Single-Arm Study (PEN-ICE)
Hongtao Duan, Changjian Shao, Minghong Pan, Honggang Liu, Xiaoping Dong, Yong Zhang, Liping Tong, Yingtong Feng, Yuanyuan Wang, Lu Wang, Neil B. Newman, Inderpal S. Sarkaria, John V. Reynolds, Francesco De Cobelli, Zhiqiang Ma, Tao Jiang, Xiaolong Yan
Producción científica: Article › revisión exhaustiva
Profundice en los temas de investigación de 'Neoadjuvant Pembrolizumab and Chemotherapy in Resectable Esophageal Cancer: An Open-Label, Single-Arm Study (PEN-ICE)'. En conjunto forman una huella única.